{"id":"W3130416374","doi":"10.1016/j.breast.2021.02.009","title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Meta-analysis; Breast cancer; Internal medicine; Oncology; Subgroup analysis; Adjuvant therapy; Population; Randomized controlled trial; MEDLINE; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01809122,0.003128085,0.01834976,0.008871615,0.000655379,0.003705249,0.002075175,0.002455846,0.001978776],"category_scores_gemma":[0.03554012,0.001832329,0.05319665,0.008416809,0.0006251923,0.001644306,0.001488342,0.00180859,0.0002365155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002930537,"about_ca_system_score_gemma":0.003516224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007797842,"about_ca_topic_score_gemma":0.01387733,"domain_scores_codex":[0.9871042,0.00626576,0.00354448,0.00128669,0.001436697,0.0003621468],"domain_scores_gemma":[0.9786943,0.01513631,0.003665551,0.0006216282,0.001621994,0.0002603194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001344274,0.00002801012,0.008029012,0.2147013,0.7672533,0.0001704054,0.0000854688,0.0009067201,0.0001838052,0.00009382525,0.0003817006,0.006822211],"study_design_scores_gemma":[0.0002414593,0.0001283007,0.004047169,0.01297851,0.9814199,0.0001100325,0.00003561748,0.0002469787,0.00007867855,0.0001057801,0.0005881102,0.0000195158],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009583718,0.9883613,0.0007081693,0.0002327171,0.0001179156,0.0002534203,0.0004936956,0.00002424001,0.0002248003],"genre_scores_gemma":[0.2944889,0.6984347,0.00339227,0.0007651788,0.0002716894,0.001320514,0.001001898,0.00003100819,0.0002938739],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01834976,"threshold_uncertainty_score":0.09567666,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01952090288958928,"score_gpt":0.2870374293321055,"score_spread":0.2675165264425162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}